Analysts expect that Davita Inc (NYSE:DVA) will announce earnings of $0.90 per share for the current quarter, according to Zacks Investment Research. Six analysts have made estimates for Davita’s earnings, with the lowest EPS estimate coming in at $0.80 and the highest estimate coming in at $0.93. Davita reported earnings of $0.81 per share during the same quarter last year, which would indicate a positive year-over-year growth rate of 11.1%. The company is expected to issue its next quarterly earnings report on Tuesday, November 6th.
According to Zacks, analysts expect that Davita will report full year earnings of $4.01 per share for the current fiscal year, with EPS estimates ranging from $3.95 to $4.04. For the next fiscal year, analysts forecast that the business will report earnings of $5.11 per share, with EPS estimates ranging from $4.34 to $6.16. Zacks’ EPS averages are an average based on a survey of research firms that follow Davita.
Davita (NYSE:DVA) last posted its earnings results on Wednesday, August 1st. The company reported $1.05 earnings per share for the quarter, beating the consensus estimate of $0.97 by $0.08. The firm had revenue of $2.89 billion during the quarter, compared to analyst estimates of $2.88 billion. Davita had a net margin of 4.30% and a return on equity of 14.49%. The business’s quarterly revenue was up 6.9% on a year-over-year basis. During the same period in the previous year, the firm earned $0.92 EPS.
Several equities analysts have recently weighed in on the stock. Zacks Investment Research raised shares of Davita from a “sell” rating to a “hold” rating in a report on Tuesday, August 7th. William Blair reaffirmed a “buy” rating on shares of Davita in a report on Wednesday, June 6th. Four equities research analysts have rated the stock with a hold rating, five have given a buy rating and two have given a strong buy rating to the company’s stock. The stock has an average rating of “Buy” and a consensus price target of $82.13.
Shares of Davita traded down $0.86, hitting $71.79, during trading on Friday, Marketbeat Ratings reports. 773,102 shares of the stock traded hands, compared to its average volume of 986,679. The company has a debt-to-equity ratio of 1.82, a current ratio of 1.90 and a quick ratio of 1.88. The firm has a market cap of $12.13 billion, a price-to-earnings ratio of 21.62, a price-to-earnings-growth ratio of 1.08 and a beta of 1.16. Davita has a 52-week low of $52.51 and a 52-week high of $80.71.
In related news, Director William L. Roper sold 1,505 shares of the business’s stock in a transaction on Tuesday, May 22nd. The shares were sold at an average price of $68.22, for a total value of $102,671.10. Following the completion of the sale, the director now owns 46,733 shares of the company’s stock, valued at approximately $3,188,125.26. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, Director Pamela M. Arway sold 1,264 shares of the business’s stock in a transaction on Thursday, June 7th. The stock was sold at an average price of $68.76, for a total transaction of $86,912.64. Following the completion of the sale, the director now directly owns 39,235 shares of the company’s stock, valued at approximately $2,697,798.60. The disclosure for this sale can be found here. In the last three months, insiders sold 3,107 shares of company stock valued at $211,976. 0.95% of the stock is owned by insiders.
A number of hedge funds and other institutional investors have recently modified their holdings of the stock. United Asset Strategies Inc. increased its holdings in Davita by 13.0% in the 2nd quarter. United Asset Strategies Inc. now owns 6,405 shares of the company’s stock worth $445,000 after acquiring an additional 735 shares in the last quarter. Janney Montgomery Scott LLC increased its holdings in Davita by 4.5% in the 2nd quarter. Janney Montgomery Scott LLC now owns 19,009 shares of the company’s stock worth $1,320,000 after acquiring an additional 811 shares in the last quarter. A.R.T. Advisors LLC increased its holdings in Davita by 0.6% in the 1st quarter. A.R.T. Advisors LLC now owns 165,500 shares of the company’s stock worth $10,913,000 after acquiring an additional 1,000 shares in the last quarter. Alps Advisors Inc. increased its holdings in Davita by 11.1% in the 2nd quarter. Alps Advisors Inc. now owns 10,781 shares of the company’s stock worth $749,000 after acquiring an additional 1,080 shares in the last quarter. Finally, LS Investment Advisors LLC increased its holdings in Davita by 14.3% in the 1st quarter. LS Investment Advisors LLC now owns 10,198 shares of the company’s stock worth $672,000 after acquiring an additional 1,277 shares in the last quarter. 85.88% of the stock is owned by institutional investors.
Davita Company Profile
DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure or end stage renal disease (ESRD). The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Davita Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Davita and related companies with MarketBeat.com's FREE daily email newsletter.